Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Aug 5, 2022
- Accession no.
- 0001493152-22-021447
- Filed
- Aug 5, 2022, 11:17 AM ET
- Trade date
- Aug 3-4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market purchases total $1.85K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $0.0955 | +$95.5 | 628,149 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +5,100 | $0.10 | +$510 | 633,249 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $0.10 | +$100 | 634,249 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +2,500 | $0.093 | +$232.5 | 636,749 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +2,600 | $0.10 | +$260 | 639,349 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $0.10 | +$500 | 644,349 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +100 | $0.11 | +$11 | 644,449 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +500 | $0.098 | +$49 | 644,949 | Direct | |
| Aug 4, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $0.093 | +$93 | 645,949 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.